Restricted accessResearch articleFirst published online 2026-4
Associations Between Clinical Parameters and Optical-Physicochemical Properties of Silicone Oil Extracted after Pars Plana Vitrectomy: An In Vitro Analysis of 35 Eyes
Silicone oil has several uses and indications in the ophthalmical field. This study aims to determine how the clinical, surgical, and patient factors influence the optical, physical, and chemical properties of silicone oil extracted from vitrectomized eyes and how these changes predispose to emulsification.
Methods:
A prospective laboratory‐based analysis was adopted. A total of 35 silicone oil samples were obtained from 35 patients who underwent pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD; 18 eyes) or non‐RRD indications (17 eyes). Ultraviolet–visible–infrared (UV–Vis–IR) spectrometry, micro-viscometry, Fourier-transform infrared (FTIR) spectroscopy, and proton nuclear magnetic resonance (1H-NMR) spectroscopy were performed. Demographic and clinical parameters, including patient age, sex, tamponade duration, PPV indication, lens status, associated cataract surgery, argon laser exposure, and postoperative glaucoma, were obtained and correlated.
Results:
Compared with control silicone oil (5,000 cSt viscosity, 77.5% visible‐light transmittance), extracted samples exhibited a lower mean viscosity (4,670.3 cSt) and reduced visible‐light transmittance (71.8%). Non‐RRD eyes showed lower transmittance but higher viscosity (4,857.5 vs. 4,493.5 cSt; P < 0.05) than RRD eyes. Argon laser exposure significantly reduced transmittance (P < 0.05) without affecting viscosity. FTIR indicated more chemical bond cleavage in non‐RRD eyes.
Conclusions:
Non-RRD eyes exhibited reduced transmittance, increased viscosity, and chemical bond disruption, which may indicate increased emulsification. Furthermore, argon laser exposure appeared to exacerbate optical clarity loss. Strategic timing of silicone oil removal and careful surgical planning may help mitigate emulsification. Further studies are required to explore more secrets of silicone oil physics.
ChenY, KearnsVR, ZhouL, et al.Silicone oil in vitreoretinal surgery: Indications, complications, new developments and alternative long-term tamponade agents. Acta Ophthalmol, 2021; 99(3):240–250; doi: 10.1111/aos.14604
BarcaF, CaporossiT, RizzoS. Silicone oil: Different physical proprieties and clinical applications. Biomed Res Int, 2014; 2014:502143.
5.
CibisPA, BeckerB, OkunE, et al.The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol, 1962; 68:590–599; doi: 10.1001/archopht.1962.00960030594005
BerkerN, BatmanC, OzdamarY, et al.Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment. Eur J Ophthalmol, 2007; 17(5):797–803; doi: 10.1177/112067210701700518
8.
SchwartzSG, FlynnHW, LeeWH, et al.Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev, 2014; 2(2):Cd006126; doi: 10.1002/14651858.CD006126.pub3
9.
ErD, ÖnerH, KayaM, et al.Evaluation of the effects of silicone oil on the macula with optical coherence tomography in patients with Rhegmatogenous retinal detachment. Turk J Ophthalmol, 2021; 51(4):218–224; doi: 10.4274/tjo.galenos.2020.48376
10.
LakitsA, NennadalT, ScholdaC, et al.Chemical stability of silicone oil in the human eye after prolonged clinical use. Ophthalmology, 1999; 106(6):1091–1100.
11.
McCurdyHH, SolomonsET. Forensic examination of toxicological specimens for dimethylpolysiloxane (silicone oil). J Analytical Toxicol, 1977; 1(5):221–223.
12.
Coman CernatCC, MunteanuM, Patoni PopescuSI, et al.Silicone oil complications in vitreoretinal surgery. Rom J Ophthalmol, 2022; 66(4):299–303; doi: 10.22336/rjo.2022.55
13.
RabinaG, AzemN, BarequetD, et al.Silicone oil tamponade effect on macular layer thickness and visual acuity. Retina, 2020; 40(5):998–1004; doi: 10.1097/iae.0000000000002464
14.
ShieldsCL, EagleRC. Pseudo-Schnabel’s cavernous degeneration of the optic nerve secondary to intraocular silicone oil. Arch Ophthalmol, 1989; 107(5):714–717; doi: 10.1001/archopht.1989.01070010732036
15.
Al-DwairiR, AhmadAA, AleshawiA, et al.Optical and physical properties of silicone oil extracted from the vitreous of patients who underwent vitrectomy for retinal detachment. J Ocul Pharmacol Ther, 2022; 38(10):717–727; doi: 10.1089/jop.2022.0081
16.
TokluY, CakmakHB, ErgunSB, et al.Time course of silicone oil emulsification. Retina, 2012; 32(10):2039–2044; doi: 10.1097/IAE.0b013e3182561f98
17.
CaramoyA, SchröderS, FauserS, et al.In vitro emulsification assessment of new silicone oils. Br J Ophthalmol, 2010; 94(4):509–512; doi: 10.1136/bjo.2009.170852
18.
StapplerT, MorphisG, IrigoyenC, et al.Is there a role for long-term silicone oil tamponade for more than twelve months in vitreoretinal surgery? Ophthalmologica, 2011; 226 (Suppl 1):36–41; doi: 10.1159/000328208
19.
CaramoyA, HagedornN, FauserS, et al.Development of Emulsification-Resistant silicone oils: Can we go beyond 2000 mPas silicone oil? Invest Ophthalmol Vis Sci, 2011; 52(8):5432–5436; doi: 10.1167/iovs.11-7250
20.
Al-DwairiR, AhmadAA, AleshawiA, et al.Silicone oil utilized in pars plana vitrectomy for patients with advanced proliferative diabetic retinopathy: Physico-Chemical and optical properties. Clin Ophthalmol, 2023; 17:3719–3728; doi: 10.2147/opth.s447099
21.
Al-DwairiR, AhmadAA, AleshawiA, et al.The influence of UV-visible light, microwave radiation, argon laser, and heating and aging processes on silicone oil utilized as intravitreal implants: Experimental exposure with clinical correlation. PLoS One, 2024; 19(12):e0316212; doi: 10.1371/journal.pone.0316212
22.
StalmansP, PinxtenAM, WongDS. Cohort safety and efficacy study of siluron2000 emulsification-resistant silicone oil and F4H5 in the treatment of full-thickness macular hole. Retina, 2015; 35(12):2558–2566; doi: 10.1097/iae.0000000000000647
23.
DikopfMS, PatelKH, SetlurVJ, et al.Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment. Eye (Lond), 2015; 29(9):1213–1219; doi: 10.1038/eye.2015.126
24.
FongDS, FerrisFL, DavisMD, et al.Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Am J Ophthalmol, 1999; 127(2):137–141; doi: 10.1016/S0002-9394(98)00309-2
25.
ReglerR, SachsHG, HillenkampJ, et al.Long-term evaluation of anatomic and functional results after complicated retinal detachment treated with pars plana vitrectomy and heavy silicone oil tamponade. Klin Monbl Augenheilkd, 2009; 226(9):707–712; doi: 10.1055/s-0028-1109685
26.
ChangPY, YangCM, YangCH, et al.Pars plana vitrectomy for diabetic fibrovascular proliferation with and without internal limiting membrane peeling. Eye (Lond), 2009; 23(4):960–965; doi: 10.1038/eye.2008.334
27.
MeierP, WiedemannP. Vitrectomy for traction macular detachment in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol, 1997; 235(9):569–574; doi: 10.1007/BF00947086
28.
SmiddyWE, FlynnHWJR. Vitrectomy in the management of diabetic retinopathy. Surv Ophthalmol, 1999; 43(6):491–507; doi: 10.1016/S0039-6257(99)00036-3
29.
SneadDR, JamesS, SneadMP. Pathological changes in the vitreoretinal junction 1: Epiretinal membrane formation. Eye (Lond), 2008; 22(10):1310–1317; doi: 10.1038/eye.2008.36
30.
TamakiK, Usui-OuchiA, MurakamiA, et al.Fibrocytes and fibrovascular membrane formation in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci, 2016; 57(11):4999–5005; doi: 10.1167/iovs.16-19798
31.
Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial–diabetic retinopathy vitrectomy study report 3. The diabetic retinopathy vitrectomy study research group. Ophthalmology, 1988; 95(10):1307–1320; doi: 10.1016/s0161-6420(88)33015-0
32.
CastellarinA, GrigorianR, BhagatN, et al.Vitrectomy with silicone oil infusion in severe diabetic retinopathy. Br J Ophthalmol, 2003; 87(3):318–321; doi: 10.1136/bjo.87.3.318
33.
MorseLS, McCuenBW. The use of silicone oil in uveitis and hypotony. Retina, 1991; 11(4):399–404; doi: 10.1097/00006982-199111040-00006
34.
LuckeKH, FoersterMH, LaquaH. Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments. Am J Ophthalmol, 1987; 104(6):624–633; doi: 10.1016/0002-9394(87)90176-0
35.
YeoJH, GlaserBM, MichelsRG. Silicone oil in the treatment of complicated retinal detachments. Ophthalmology, 1987; 94(9):1109–1113; doi: 10.1016/s0161-6420(87)33328-7
36.
BrourmanND, BlumenkranzMS, CoxMS, et al.Silicone oil for the treatment of severe proliferative diabetic retinopathy. Ophthalmology, 1989; 96(6):759–764; doi: 10.1016/s0161-6420(89)32828-4
37.
AzenSP, ScottIU, FlynnHW, et al.Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter study. Ophthalmology, 1998; 105(9):1587–1597; doi: 10.1016/s0161-6420(98)99023-6
38.
SinisiF, Della SantinaM, LoiudiceP, et al.The role of silicone oil in the surgical management of endophthalmitis: A systematic review. J Clin Med, 2022; 11(18):5445; doi: 10.3390/jcm11185445
39.
NagpalM, JainP, NagpalK. Pars plana vitrectomy with or without silicone oil endotamponade in surgical management of endophthalmitis. Asia Pac J Ophthalmol (Phila), 2012; 1(4):216–221; doi: 10.1097/APO.0b013e31826000cd
40.
AzadR, RaviK, TalwarD, et al.Pars plana vitrectomy with or without silicone oil endotamponade in post-traumatic endophthalmitis. Graefes Arch Clin Exp Ophthalmol, 2003; 241(6):478–483; doi: 10.1007/s00417-003-0670-4
41.
DoT, HonDN, AungT, et al.Bacterial endogenous endophthalmitis in Vietnam: A randomized controlled trial comparing vitrectomy with silicone oil versus vitrectomy alone. Clin Ophthalmol, 2014; 8:1633–1640; doi: 10.2147/opth.s67589
42.
Ivanovska-AdjievskaB, BoskurtS, SemizF, et al.Treatment of idiopathic macular hole with silicone oil tamponade. Clin Ophthalmol, 2012; 6:1449–1454; doi: 10.2147/opth.s33902
43.
HeidenkummerHP, KampikA, ThierfelderS. Emulsification of silicone oils with specific physicochemical characteristics. Graefes Arch Clin Exp Ophthalmol, 1991; 229(1):88–94; doi: 10.1007/bf00172269
44.
YilmazT, GülerM. The role of nystagmus in silicone oil emulsification after pars plana vitrectomy and silicone oil injection for complex retinal detachment. Eur J Ophthalmol, 2008; 18(1):150–154; doi: 10.1177/112067210801800128
45.
MohalhalAA, El ShazlyMI, GhalwashDA. Effect of lens status on intraocular pressure in siliconized eyes. Clin Ophthalmol, 2012; 6:265–268; doi: 10.2147/opth.s28623
46.
LiuJ, WangG, ShiM, et al.BTK and YKL-40 levels and their association with acute AQP4-IgG-Positive neuromyelitis optica spectrum disorder. Mol Neurobiol, 2025; 62(4):4785–4801; doi: 10.1007/s12035-024-04588-5
47.
WangG, JingL, WangY, et al.Interferon regulatory factor 5 gene polymorphisms and mRNA expression levels are associated with neuromyelitis optica spectrum disorder. Mol Neurobiol, 2024; 61(10):7989–7999; doi: 10.1007/s12035-024-04072-0
48.
MehmoodA, ShahS, GuoRY, et al.Methyl-CpG-Binding protein 2 emerges as a central player in multiple sclerosis and neuromyelitis optica spectrum disorders. Cell Mol Neurobiol, 2023; 43(8):4071–4101; doi: 10.1007/s10571-023-01432-7
49.
KhanM, ShahS, LvB, et al.Molecular mechanisms of Alu and LINE-1 interspersed repetitive sequences reveal diseases of visual system dysfunction. Ocul Immunol Inflamm, 2023; 31(9):1848–1858; doi: 10.1080/09273948.2022.2112238
50.
MehmoodA, AliW, SongS, et al.Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis. Brain Behav, 2021; 11(10):e2302; doi: 10.1002/brb3.2302
